Showing posts from March 3, 2015

Rural Electrification Corporation

RECLTD (362) - Hereafter support 354-348
Above that upside target 380--390  & 410-420

But afterwards , ready for big up move 

Reliance Infrastructure

RELINFRA  (479) -  Posted on 12th Feb as " support 415-405 above that upside target 454--474"

As posted, the mentioned target already attacked on 20th Feb itself  (made high 475.50) , not only that , from there , corrected up to 449 and now once again moving up and in the last two days it closed above 474.

now what next ? 

Above 474-464

next upside target and resistance  520-540

But above that next upside target  640-660


VOLTAS (273) - Face Resistance 285--297
But above that 
next upside target 337--347
and above that , Already mentioned on 03rd Nov 2014 
remain same and intact . 
in between resist at 405-420

Yes Bank

YESBANK (882) - Posted on 10th Feb as "Hope and support 790-780"

After this post, it took support at 790-780 on 10th Feb itself and once again on 26th Feb , as on yesterday it made high 888.

Now what next ? 

Face resist at 890-910

But trade and stays above that 
next upside target 1000-1020

Sun Pharma’s Dilip Shanghvi Overtakes Mukesh Ambani As The Richest Indian ; Once again,Bill Gates on top globally

As per Forbes Rich List 2015, Mukesh Ambani has retained his position as the richest Indian for the eighth year in a rowwith a net worth of $21 billion.
Among the 90 Indians on the Forbes Rich List 2015, published today, Ambani (39th globally) is closely followed by pharmaceuticals business tycoon Dilip Shanghvi (44th rank with networth of $ 20 billion) and Azim Premji (48th with $ 19.1 billion).

But as on latest, Sun Pharma’s Dilip Shanghvi Overtakes Mukesh Ambani 

Dilip Shanghvi, the 59-year-old promoter of Sun Pharma, appears to have overtaken Mukesh Ambani (57) of Reliance Industries Ltd (RIL) as the richest Indian if one goes by the promoter holdings in the listed companies of the two groups.At Thursday's close of trading on BSE, the Gujarat-born and Kolkata-educated Shanghvi, by virtue of his over 63% holding in three group companies — Sun Pharma, Sun Pharma Advanced Research and Ranbaxy Labs — is worth about Rs 1.46 lakh crore ($23.42 billion at an exchange rate

If you take, as…